33.5% gain in some days ->Time to cash out

On April the 5th we posted a Trade Idea for Blueprint Medicines Corporation (BPMC) at 59.69.

With a recent price(Friday close) of 70.69& a 33.5% gain in 21 days , we would cash out.

Even though the company still represents a long term opportunity for the patient investors, the volatility of biotech industry & the present risk/reward ratio favors at least the partial(>60%) close of the position.


Leave a comment